101 related articles for article (PubMed ID: 21315586)
61. Synthesis and biological evaluation of imidazol-2-one derivatives as potential antitumor agents.
Xue N; Yang X; Wu R; Chen J; He Q; Yang B; Lu X; Hu Y
Bioorg Med Chem; 2008 Mar; 16(5):2550-7. PubMed ID: 18226907
[TBL] [Abstract][Full Text] [Related]
62. Simple and efficient synthesis of novel glycosyl thiourea derivatives as potential antitumor agents.
Shusheng Z; Tianrong Z; Kun C; Youfeng X; Bo Y
Eur J Med Chem; 2008 Dec; 43(12):2778-83. PubMed ID: 18313175
[TBL] [Abstract][Full Text] [Related]
63. Synthesis of 2,6-diaryl-substituted pyridines and their antitumor activities.
Son JK; Zhao LX; Basnet A; Thapa P; Karki R; Na Y; Jahng Y; Jeong TC; Jeong BS; Lee CS; Lee ES
Eur J Med Chem; 2008 Apr; 43(4):675-82. PubMed ID: 17673337
[TBL] [Abstract][Full Text] [Related]
64. Synthesis, structural characterisation and anti-proliferative activity of NHC gold amino acid and peptide conjugates.
Lemke J; Pinto A; Niehoff P; Vasylyeva V; Metzler-Nolte N
Dalton Trans; 2009 Sep; (35):7063-70. PubMed ID: 20449149
[TBL] [Abstract][Full Text] [Related]
65. A facile 'click' approach to novel 15β-triazolyl-5α-androstane derivatives, and an evaluation of their antiproliferative activities in vitro.
Kádár Z; Molnár J; Schneider G; Zupkó I; Frank É
Bioorg Med Chem; 2012 Feb; 20(4):1396-402. PubMed ID: 22277592
[TBL] [Abstract][Full Text] [Related]
66. Effect of Wnt inhibitors in pancreatic cancer.
Wall I; Schmidt-Wolf IG
Anticancer Res; 2014 Oct; 34(10):5375-80. PubMed ID: 25275031
[TBL] [Abstract][Full Text] [Related]
67. Targeting renal cancer with a combination of WNT inhibitors and a bi-functional peptide.
Koller CM; Kim Y; Schmidt-Wolf IG
Anticancer Res; 2013 Jun; 33(6):2435-40. PubMed ID: 23749892
[TBL] [Abstract][Full Text] [Related]
68. Improvement of the Chemical Reactivity of Michael Acceptor of Ethacrynic Acid Correlates with Antiproliferative Activities.
El Abbouchi A; El Brahmi N; Hiebel MA; Ghammaz H; El Fahime E; Bignon J; Guillaumet G; Suzenet F; El Kazzouli S
Molecules; 2023 Jan; 28(2):. PubMed ID: 36677966
[TBL] [Abstract][Full Text] [Related]
69. 3-Deoxy-3,4-dehydro analogs of XM462. Preparation and activity on sphingolipid metabolism and cell fate.
Camacho L; Simbari F; Garrido M; Abad JL; Casas J; Delgado A; Fabriàs G
Bioorg Med Chem; 2012 May; 20(10):3173-9. PubMed ID: 22537678
[TBL] [Abstract][Full Text] [Related]
70. [123I]Iodooctyl fenbufen amide as a SPECT tracer for imaging tumors that over-express COX enzymes.
Huang HL; Yeh CN; Lee WY; Huang YC; Chang KW; Lin KJ; Tien SF; Su WC; Yang CH; Chen JT; Lin WJ; Fan SS; Yu CS
Biomaterials; 2013 Apr; 34(13):3355-65. PubMed ID: 23384791
[TBL] [Abstract][Full Text] [Related]
71. 4-Phenyl-4-oxo-butanoic acid derivatives inhibitors of kynurenine 3-hydroxylase.
Giordani A; Pevarello P; Cini M; Bormetti R; Greco F; Toma S; Speciale C; Varasi M
Bioorg Med Chem Lett; 1998 Oct; 8(20):2907-12. PubMed ID: 9873646
[TBL] [Abstract][Full Text] [Related]
72. Synthesis and biological evaluation of 20-epi-amino-20-deoxysalinomycin derivatives.
Li Y; Shi Q; Shao J; Yuan Y; Yang Z; Chen S; Zhou X; Wen S; Jiang ZX
Eur J Med Chem; 2018 Mar; 148():279-290. PubMed ID: 29466777
[TBL] [Abstract][Full Text] [Related]
73. Advances at the intersection of chemical biology and medicinal chemistry.
Tavassoli A
Future Med Chem; 2015; 7(16):2089-90. PubMed ID: 26571116
[No Abstract] [Full Text] [Related]
74. Potential of Phenylbutyrate as Adjuvant Chemotherapy: An Overview of Cellular and Molecular Anticancer Mechanisms.
Al-Keilani MS; Al-Sawalha NA
Chem Res Toxicol; 2017 Oct; 30(10):1767-1777. PubMed ID: 28930444
[TBL] [Abstract][Full Text] [Related]
75. Inhibitory effects of ethacrynic acid analogues lacking the α,β-unsaturated carbonyl unit and para-acylated phenols on human cancer cells.
Bryant ZE; Janser RF; Jabarkhail M; Candelaria-Lyons MS; Romero BB; Van slambrouck S; Steelant WF; Janser I
Bioorg Med Chem Lett; 2011 Feb; 21(3):912-5. PubMed ID: 21227691
[TBL] [Abstract][Full Text] [Related]
76. α-Ketothioamide Derivatives: A Promising Tool to Interrogate Phosphoglycerate Dehydrogenase (PHGDH).
Ravez S; Corbet C; Spillier Q; Dutu A; Robin AD; Mullarky E; Cantley LC; Feron O; Frédérick R
J Med Chem; 2017 Feb; 60(4):1591-1597. PubMed ID: 28085281
[TBL] [Abstract][Full Text] [Related]
77. New non-peptidic inhibitors of papain derived from etacrynic acid.
Kaeppler U; Schirmeister T
Med Chem; 2005 Jul; 1(4):361-70. PubMed ID: 16789893
[TBL] [Abstract][Full Text] [Related]
78. GAC inhibitors with a 4-hydroxypiperidine spacer: Requirements for potency.
McDermott L; Koes D; Mohammed S; Iyer P; Boby M; Balasubramanian V; Geedy M; Katt W; Cerione R
Bioorg Med Chem Lett; 2019 Oct; 29(19):126632. PubMed ID: 31474484
[TBL] [Abstract][Full Text] [Related]
79. Target Fishing by Cross-Docking to Explain Polypharmacological Effects.
Patel H; Lucas X; Bendik I; Günther S; Merfort I
ChemMedChem; 2015 Jul; 10(7):1209-17. PubMed ID: 26033840
[TBL] [Abstract][Full Text] [Related]
80. Ethacrynic acid analogues lacking the alpha,beta-unsaturated carbonyl unit--potential anti-metastatic drugs.
Janser RF; Meka RK; Bryant ZE; Adogla EA; Vogel EK; Wharton JL; Tilley CM; Kaminski CN; Ferrey SL; Van Slambrouck S; Steelant WF; Janser I
Bioorg Med Chem Lett; 2010 Mar; 20(6):1848-50. PubMed ID: 20172724
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
